Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Oxitriptan or 5-HTP is a metabolite of the natural amino acid L-Tryptophan, a component of proteins. In turn it is the immediate precursor of serotonin.
It is abundantly found in the seeds of the African plant griffonia simplicifolia (Rondanelli 2012).
It is used as an antidepressant, to treat fibromyalgia, neurological disorders, headaches, insomnia and obesity with controversy over the lack of evidence of its effetiveness (MedlinePlus 2016, Shaw 2002, Alt Med Rev 1998).
Levels of 5-HTP and tryptophan decrease in the mother during childbirth, while they increase in cord blood (Carretti 2003).
Like L-Tryptophan, its use has been associated with a serious epidemic of eosinophilia-myalgia syndrome with more than 1,500 cases and 37 deaths occurring in the 1990s, possibly caused by contaminated or poorly prepared batches of tryptophan (Medline Plus 2016, Klarskov 2003, Klarskov 1999, Michelson 1994).
The FDA has not authorized its as a drug.
Since the last update we have not found any published data on its excretion in breast milk.
Its pharmacokinetic data (low molecular weight, low protein binding, low volume of distribution) make it likely that it would pass into breast milk in amounts which could be significant.
It can increase prolactin levels (Lancranjan 1977).
Due to the lack of evidence on its efficacy and the possibility of side effects, it is a drug that is non-essential during breastfeeding.
If used, very moderate consumption is recommended and and it must come from a reliable source, given the poisonings that have previously occurred (Medline Plus 2016).
See below the information of this related product: